BIOMAT Database Logo BIOMAT Database Logo

Active specific immunotherapy with antiidiotypic antibodies in patients with solid tumors. 1989

M J O'Connell, and Z J Chen, and H Yang, and M Yamada, and M Massaro, and A Mittelman, and S Ferrone
Department of Microbiology and Immunology, New York Medical College, Valhalla 10595.

Tumor-associated antigens (TAA) provide appropriate targets for selective manipulation of the patient's immune response in the immunotherapy of cancer. Active specific immunotherapy utilizing antiidiotypic antibodies to anti-TAA antibodies has been implemented in phase I clinical trials both in patients with colorectal carcinoma and in those with melanoma. The theoretical basis for immunotherapy with antiidiotypic antibodies, the results of these clinical trials, and an evaluation of appropriate parameters for future clinical trials of active specific immunotherapy with antiidiotypic antibodies in patients with solid tumors are reviewed.

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D012004 Rectal Neoplasms Tumors or cancer of the RECTUM. Cancer of Rectum,Rectal Cancer,Rectal Tumors,Cancer of the Rectum,Neoplasms, Rectal,Rectum Cancer,Rectum Neoplasms,Cancer, Rectal,Cancer, Rectum,Neoplasm, Rectal,Neoplasm, Rectum,Rectal Cancers,Rectal Neoplasm,Rectal Tumor,Rectum Cancers,Rectum Neoplasm,Tumor, Rectal
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000888 Antibodies, Anti-Idiotypic Antibodies which react with the individual structural determinants (idiotopes) on the variable region of other antibodies. Anti-Antibodies,Anti-Idiotype Antibodies,Antibodies, Internal Image,Antigamma Globulin Antibodies,Antiglobulins,Anti Antibodies,Anti-gamma Globulin Antibodies,Anti Idiotype Antibodies,Anti gamma Globulin Antibodies,Anti-Idiotypic Antibodies,Antibodies, Anti,Antibodies, Anti Idiotypic,Antibodies, Anti-Idiotype,Antibodies, Anti-gamma Globulin,Antibodies, Antigamma Globulin,Globulin Antibodies, Anti-gamma,Globulin Antibodies, Antigamma,Image Antibodies, Internal,Internal Image Antibodies
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

M J O'Connell, and Z J Chen, and H Yang, and M Yamada, and M Massaro, and A Mittelman, and S Ferrone
Active specific immunotherapy of human solid tumors.
March 1978, Virginia medical,
M J O'Connell, and Z J Chen, and H Yang, and M Yamada, and M Massaro, and A Mittelman, and S Ferrone
Active specific immunotherapy of human solid tumors.
January 1976, Annals of the New York Academy of Sciences,
M J O'Connell, and Z J Chen, and H Yang, and M Yamada, and M Massaro, and A Mittelman, and S Ferrone
Feasibility study of active immunotherapy in patients with solid tumors.
July 1976, Cancer,
M J O'Connell, and Z J Chen, and H Yang, and M Yamada, and M Massaro, and A Mittelman, and S Ferrone
Active specific immunotherapy in patients with melanoma. A clinical trial with mouse antiidiotypic monoclonal antibodies elicited with syngeneic anti-high-molecular-weight-melanoma-associated antigen monoclonal antibodies.
December 1990, The Journal of clinical investigation,
M J O'Connell, and Z J Chen, and H Yang, and M Yamada, and M Massaro, and A Mittelman, and S Ferrone
Systemic specific active immunotherapy for solid tumors. An overview about cancer vaccinetherapy.
December 1994, Recenti progressi in medicina,
M J O'Connell, and Z J Chen, and H Yang, and M Yamada, and M Massaro, and A Mittelman, and S Ferrone
DNA-specific antiidiotypic antibodies in the sera of patients with autoimmune diseases.
December 1992, FEBS letters,
M J O'Connell, and Z J Chen, and H Yang, and M Yamada, and M Massaro, and A Mittelman, and S Ferrone
Targets for active immunotherapy against pediatric solid tumors.
June 2009, Cancer immunology, immunotherapy : CII,
M J O'Connell, and Z J Chen, and H Yang, and M Yamada, and M Massaro, and A Mittelman, and S Ferrone
Monoclonal antibodies specific immunotherapy of gastrointestinal tumors.
July 1986, Hybridoma,
M J O'Connell, and Z J Chen, and H Yang, and M Yamada, and M Massaro, and A Mittelman, and S Ferrone
[Active immunotherapy in patients with hematologic and solid neoplasms].
October 2005, Onkologie,
M J O'Connell, and Z J Chen, and H Yang, and M Yamada, and M Massaro, and A Mittelman, and S Ferrone
Active specific and active non-specific immunotherapy in patients with malignant melanoma.
January 1977, Oncology,
Copied contents to your clipboard!